Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Government should allow same level of operational freedom to its experts in procurement in healthcare as it has in defence: MTaI

      Government should allow same level of operational freedom to its experts in procurement in healthcare as it has in defence: MTaI

      Ruby Khatun Khatun17 April 2018 10:15 AM IST
      New Delhi: Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with significant...
      AffordPlan raises 10 million dollar led by Lok Capital

      AffordPlan raises 10 million dollar led by Lok Capital

      Ruby Khatun Khatun17 April 2018 10:10 AM IST
      New Delhi: AffordPlan, a healthcare-focused fintech company said it has raised $10 million in funding led by Lok Capital.The series B funding round...
      Bristol-Myers says cancer drug combo reduces death risk

      Bristol-Myers says cancer drug combo reduces death risk

      Ruby Khatun Khatun17 April 2018 10:00 AM IST
      Bristol-Myers Squibb said on Monday its cancer drugs, Opdivo and Yervoy, reduced the risk of the disease spreading or death in previously untreated...
      Google unveils vetting process for drug rehab ads

      Google unveils vetting process for drug rehab ads

      Ruby Khatun Khatun17 April 2018 9:45 AM IST
      SAN FRANCISCO: Google told Reuters it would resume accepting ads from U.S. addiction treatment centers in July, nearly a year after the Alphabet Inc...
      Johnson and Johnson Baby Powder litigation takes new focus with asbestos claims

      Johnson and Johnson Baby Powder litigation takes new focus with asbestos claims

      Ruby Khatun Khatun17 April 2018 9:30 AM IST
      NEW YORK: A $117 million verdict against Johnson and Johnson and a supplier in favor of a man who said his asbestos-related cancer was caused by...
      Govt to define stem cells as DRUG, regulate use in therapy

      Govt to define stem cells as DRUG, regulate use in therapy

      Ruby Khatun Khatun16 April 2018 4:48 PM IST
      New Delhi: Ministry Of Health and Family Welfare has proposed the further amendment to the Drugs and Cosmetics Act bringing down the stem cells under...
      Cipla arm recalls multiple lots of antidepressant drug from US

      Cipla arm recalls multiple lots of antidepressant drug from US

      Ruby Khatun Khatun16 April 2018 10:30 AM IST
      New Delhi: Pharma major Cipla's arm InvaGen Pharmaceuticals Inc is recalling 11 lots of antidepressant bupropion HCl extended-release tablets from the...
      Next Gen Pharma launches Roidosanal for treatment of Haemorrhoids, Backed with Clinical Studies

      Next Gen Pharma launches Roidosanal for treatment of Haemorrhoids, Backed with Clinical Studies

      Ruby Khatun Khatun16 April 2018 10:16 AM IST
      Delhi: Next Gen Pharma India Pvt. Ltd. (Next Gen Pharma) is a speciality pharma startup offering niche products/solutions backed by sound evidence and...
      Bristol-Myers Squibb collaborates with Harvard for new fibrosis research

      Bristol-Myers Squibb collaborates with Harvard for new fibrosis research

      Ruby Khatun Khatun16 April 2018 10:00 AM IST
      Bristol-Myers Squibb Company and the Harvard Fibrosis Network of the Harvard Stem Cell Institute announced a research collaboration to discover and...
      Orchard Therapeutics acquires GSKs rare disease gene therapy portfolio

      Orchard Therapeutics acquires GSK's rare disease gene therapy portfolio

      Ruby Khatun Khatun16 April 2018 9:45 AM IST
      GSK and Orchard Therapeutics announced a strategic agreement, under which GSK will transfer its portfolio of approved and investigational rare disease...
      Canadian pharmacy to be fined millions for illegal imports

      Canadian pharmacy to be fined millions for illegal imports

      Ruby Khatun Khatun16 April 2018 9:30 AM IST
      An online pharmacy that bills itself as Canada's largest is expected to be fined USD 34 million for importing counterfeit cancer drugs and other...
      Mosquitoes, gnats in Plant; no quality control: USFDA investigators Observe on Alkem Plant

      Mosquitoes, gnats in Plant; no quality control: USFDA investigators Observe on Alkem Plant

      Ruby Khatun Khatun15 April 2018 12:21 PM IST
      New Delhi: The USFDA investigators has found mosquitoes and gnats in the manufacturing unit of Alkem Laboratories Ltd at Daman during a recent...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok